✦ LIBER ✦

Clinical-Histological Correlation in Diabetic and Idiopathic Gastroparesis: Results From the NIDDK Gastroparesis Clinical Research Consortium

✍ Scribed by Madhusudan Grover; Pankaj J. Pasricha; Henry P. Parkman; Cheryl E. Bernard; Matthew S. Lurken; Thomas L. Abell; William J. Snape; William L. Hasler; Aynur Unalp-Arida; Linda Anh B. Nguyen; Kenneth L. Koch; Jorge Calles; Linda A. Lee; James Tonascia; Frank A. Hamilton; Gianrico Farrugia

Book ID: 119432136
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 40 KB
Volume: 140
Category: Article
ISSN: 0016-5085
DOI: 10.1016/s0016-5085(11)60288-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical-histological associations in ga

Clinical-histological associations in gastroparesis: results from the Gastroparesis Clinical Research Consortium

✍ M. Grover; C. E. Bernard; P. J. Pasricha; M. S. Lurken; M. S. Faussone-Pellegrin 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 468 KB

W1393 Symptomatic Heterogeneity Between

W1393 Symptomatic Heterogeneity Between Diabetic and Idiopathic Gastroparesis: Analysis of Data From the NIDDK Gastroparesis Clinical Research Consortium Registry

✍ Parkman, Henry P.; Pasricha, Pankaj J.; Hasler, William L.; Farrugia, Gianrico; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 58 KB

792 Mortality and Predictors of Improvem

792 Mortality and Predictors of Improvement in Patients With Gastroparesis: 4-Year Outcomes From the Gastroparesis Clinical Research Consortium

✍ Pasricha, Pankaj J.; Yates, Katherine P.; Clarke, John O.; Unalp, Aynur; Tonasci 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Ultrastructural differences between diab

Ultrastructural differences between diabetic and idiopathic gastroparesis

✍ Maria Simonetta Faussone-Pellegrini; Madhusudan Grover; Pankaj J. Pasricha; Cher 📂 Article 📅 2012 🏛 Carol Davila University of Medicine Bucharest, Rom 🌐 English ⚖ 705 KB

Can multiparametric magnetic resonance i

Can multiparametric magnetic resonance imaging predict upgrading of transrectal ultrasound biopsy results at more definitive histology?11Mohamed Abd-Alazeez receives funding from the Egyptian government. Mark Emberton and Hashim U. Ahmed receive funding from USHIFU and Advanced Medical Diagnostics for clinical trials. Mark Emberton is a paid consultant for Steba Biotech, USHIFU and Sanofi-Aventis. Mark Emberton has received research support by GSK for a study evaluating the role of MRI in men with prostate cancer. Mark Emberton and Hashim Ahmed have previously received medical consultancy fees from GE Healthcare/Oncura and Hashim Ahmed previously from Steba Biotech. Mark Emberton is a medical director of Mediwatch PLC. Hashim Uddin Ahmed and Mark Emberton receive funding from the Medical Research Council, the NIHR-HTA, NIHR-i4i, the US NIH/NCI, Pelican Cancer Foundation, Prostate Cancer UK, and St Peter׳s Trust. This work was part funded by research support for Mark Emberton and Alex Kirkham from the UK National Institute of Health Research UCLH/UCL Comprehensive Biomedical Research Centre, London, UK.

✍ Abd-Alazeez, Mohamed; Ahmed, Hashim U.; Arya, Manit; Allen, Clare; Dikaios, Niko 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 415 KB